| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Environmental Health | 15 | 2023 | 43 | 4.870 |
Why?
|
| Water Pollutants, Chemical | 17 | 2023 | 171 | 4.710 |
Why?
|
| Oxidative Stress | 25 | 2020 | 1003 | 4.540 |
Why?
|
| Oryzias | 8 | 2023 | 9 | 4.360 |
Why?
|
| DNA Damage | 24 | 2020 | 356 | 4.310 |
Why?
|
| Oxides | 20 | 2022 | 100 | 3.990 |
Why?
|
| Environmental Pollutants | 15 | 2018 | 201 | 3.100 |
Why?
|
| Graphite | 8 | 2023 | 64 | 2.910 |
Why?
|
| Arsenicals | 15 | 2021 | 87 | 2.790 |
Why?
|
| Apoptosis | 18 | 2024 | 1568 | 2.730 |
Why?
|
| Mutagens | 9 | 2018 | 74 | 2.720 |
Why?
|
| Lead | 10 | 2015 | 100 | 2.640 |
Why?
|
| Leukemia, Promyelocytic, Acute | 5 | 2022 | 19 | 2.590 |
Why?
|
| Nanotubes, Carbon | 9 | 2018 | 87 | 2.580 |
Why?
|
| Antineoplastic Agents | 13 | 2022 | 1019 | 2.380 |
Why?
|
| Plant Extracts | 7 | 2024 | 302 | 2.110 |
Why?
|
| Liver | 11 | 2023 | 511 | 2.090 |
Why?
|
| Public Health | 7 | 2025 | 424 | 1.980 |
Why?
|
| Chromosome Aberrations | 8 | 2015 | 61 | 1.930 |
Why?
|
| Environmental Exposure | 13 | 2018 | 256 | 1.890 |
Why?
|
| Biomedical Research | 6 | 2025 | 502 | 1.840 |
Why?
|
| Research | 9 | 2016 | 181 | 1.770 |
Why?
|
| Metal Nanoparticles | 7 | 2022 | 230 | 1.750 |
Why?
|
| Cisplatin | 4 | 2022 | 98 | 1.740 |
Why?
|
| Comet Assay | 17 | 2020 | 77 | 1.700 |
Why?
|
| Humans | 108 | 2025 | 43102 | 1.630 |
Why?
|
| Air Pollutants | 5 | 2023 | 130 | 1.610 |
Why?
|
| Vernonia | 5 | 2020 | 15 | 1.610 |
Why?
|
| Animals | 64 | 2026 | 16992 | 1.600 |
Why?
|
| Cell Survival | 17 | 2016 | 945 | 1.550 |
Why?
|
| Reactive Oxygen Species | 12 | 2019 | 532 | 1.530 |
Why?
|
| Liver Neoplasms | 11 | 2012 | 224 | 1.490 |
Why?
|
| Air Pollution | 5 | 2023 | 87 | 1.450 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2024 | 134 | 1.360 |
Why?
|
| Bone Marrow Cells | 5 | 2015 | 79 | 1.330 |
Why?
|
| Minority Groups | 8 | 2025 | 690 | 1.240 |
Why?
|
| Chromium | 4 | 2010 | 28 | 1.230 |
Why?
|
| Plant Leaves | 4 | 2024 | 136 | 1.220 |
Why?
|
| Metals, Heavy | 4 | 2015 | 71 | 1.220 |
Why?
|
| Neoplasms | 4 | 2024 | 1377 | 1.210 |
Why?
|
| Silver | 3 | 2015 | 61 | 1.200 |
Why?
|
| Carcinogens, Environmental | 4 | 2018 | 35 | 1.160 |
Why?
|
| Health Status Disparities | 5 | 2019 | 719 | 1.160 |
Why?
|
| Endocrine Disruptors | 2 | 2026 | 44 | 1.080 |
Why?
|
| Arsenic | 4 | 2019 | 155 | 1.050 |
Why?
|
| Mercury | 4 | 2012 | 39 | 1.030 |
Why?
|
| Hepatocytes | 6 | 2011 | 80 | 1.020 |
Why?
|
| Ovarian Neoplasms | 2 | 2022 | 415 | 1.020 |
Why?
|
| Zebrafish | 2 | 2026 | 146 | 1.000 |
Why?
|
| Lipid Peroxidation | 13 | 2019 | 140 | 1.000 |
Why?
|
| Cell Proliferation | 10 | 2024 | 1455 | 1.000 |
Why?
|
| Kidney | 4 | 2016 | 372 | 0.990 |
Why?
|
| Neurotoxins | 1 | 2026 | 57 | 0.950 |
Why?
|
| Plants, Medicinal | 2 | 2023 | 57 | 0.910 |
Why?
|
| Nitrates | 3 | 2015 | 63 | 0.910 |
Why?
|
| Ozone | 5 | 2016 | 26 | 0.890 |
Why?
|
| Ocimum | 1 | 2024 | 4 | 0.870 |
Why?
|
| Malathion | 4 | 2011 | 8 | 0.860 |
Why?
|
| Dinitrobenzenes | 4 | 2005 | 17 | 0.840 |
Why?
|
| Trust | 2 | 2023 | 167 | 0.830 |
Why?
|
| Acetylcysteine | 3 | 2010 | 57 | 0.830 |
Why?
|
| Awards and Prizes | 2 | 2015 | 28 | 0.820 |
Why?
|
| Publishing | 2 | 2015 | 28 | 0.820 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 1092 | 0.820 |
Why?
|
| Mississippi | 8 | 2023 | 129 | 0.810 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 495 | 0.800 |
Why?
|
| HL-60 Cells | 8 | 2015 | 33 | 0.800 |
Why?
|
| Interrenal Gland | 1 | 2022 | 1 | 0.760 |
Why?
|
| Pesticides | 4 | 2011 | 62 | 0.750 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 38 | 0.730 |
Why?
|
| Vaccines | 1 | 2022 | 65 | 0.720 |
Why?
|
| Male | 31 | 2023 | 23409 | 0.710 |
Why?
|
| Nanoparticles | 3 | 2019 | 460 | 0.700 |
Why?
|
| Larva | 5 | 2022 | 133 | 0.700 |
Why?
|
| Catalase | 5 | 2019 | 110 | 0.660 |
Why?
|
| Cadmium Chloride | 2 | 2016 | 10 | 0.650 |
Why?
|
| Superoxide Dismutase | 5 | 2019 | 158 | 0.650 |
Why?
|
| Proto-Oncogene Proteins c-fos | 9 | 2009 | 83 | 0.650 |
Why?
|
| Biological Products | 1 | 2022 | 91 | 0.640 |
Why?
|
| Coronavirus | 1 | 2020 | 9 | 0.640 |
Why?
|
| Infection Control | 1 | 2020 | 18 | 0.640 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 165 | 0.620 |
Why?
|
| Caspase 3 | 7 | 2015 | 227 | 0.620 |
Why?
|
| Reproduction | 1 | 2020 | 94 | 0.620 |
Why?
|
| Environmental Monitoring | 10 | 2023 | 230 | 0.610 |
Why?
|
| Models, Theoretical | 3 | 2010 | 232 | 0.610 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2015 | 1124 | 0.600 |
Why?
|
| Crassostrea | 1 | 2019 | 4 | 0.600 |
Why?
|
| Zinc | 2 | 2019 | 131 | 0.590 |
Why?
|
| Antioxidants | 4 | 2019 | 443 | 0.590 |
Why?
|
| Carcinogens | 2 | 2012 | 126 | 0.590 |
Why?
|
| Ecosystem | 5 | 2022 | 175 | 0.590 |
Why?
|
| Methyl Parathion | 2 | 2011 | 2 | 0.590 |
Why?
|
| Arsenates | 1 | 2018 | 26 | 0.580 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 175 | 0.580 |
Why?
|
| Insecticides | 3 | 2011 | 54 | 0.580 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2012 | 163 | 0.570 |
Why?
|
| Phytotherapy | 1 | 2019 | 75 | 0.570 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.570 |
Why?
|
| Anticarcinogenic Agents | 1 | 2019 | 77 | 0.570 |
Why?
|
| Arsenites | 1 | 2018 | 54 | 0.560 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.560 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 108 | 0.560 |
Why?
|
| Adenocarcinoma | 3 | 2024 | 291 | 0.560 |
Why?
|
| Cell Line, Tumor | 12 | 2021 | 2676 | 0.550 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2018 | 15 | 0.550 |
Why?
|
| Fibroblasts | 2 | 2010 | 281 | 0.550 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 137 | 0.550 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2018 | 49 | 0.540 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 54 | 0.540 |
Why?
|
| HSP70 Heat-Shock Proteins | 8 | 2014 | 57 | 0.540 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 178 | 0.540 |
Why?
|
| Herbicides | 1 | 2018 | 43 | 0.530 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2019 | 1766 | 0.530 |
Why?
|
| Pentachlorophenol | 4 | 2006 | 4 | 0.530 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 539 | 0.530 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 80 | 0.530 |
Why?
|
| Phosphatidylserines | 3 | 2010 | 22 | 0.530 |
Why?
|
| Wind | 1 | 2017 | 12 | 0.520 |
Why?
|
| Neoplasm Proteins | 3 | 2014 | 228 | 0.520 |
Why?
|
| Gold | 1 | 2019 | 156 | 0.520 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 220 | 0.510 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 280 | 0.510 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2020 | 863 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 196 | 0.500 |
Why?
|
| Prostatic Hyperplasia | 1 | 2016 | 32 | 0.490 |
Why?
|
| Female | 19 | 2023 | 24698 | 0.490 |
Why?
|
| Leukemia | 2 | 2014 | 54 | 0.490 |
Why?
|
| Hep G2 Cells | 6 | 2016 | 63 | 0.480 |
Why?
|
| Water Microbiology | 4 | 2006 | 81 | 0.480 |
Why?
|
| Tumor Cells, Cultured | 7 | 2020 | 508 | 0.480 |
Why?
|
| Environment | 3 | 2016 | 149 | 0.480 |
Why?
|
| Enterobacteriaceae | 2 | 2006 | 30 | 0.470 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 4 | 2022 | 140 | 0.470 |
Why?
|
| Manure | 2 | 2005 | 7 | 0.460 |
Why?
|
| Escherichia coli Infections | 2 | 2006 | 45 | 0.450 |
Why?
|
| Health Services Research | 3 | 2018 | 161 | 0.450 |
Why?
|
| Congresses as Topic | 2 | 2014 | 50 | 0.450 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 1723 | 0.450 |
Why?
|
| Cell Cycle | 5 | 2020 | 346 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2022 | 968 | 0.440 |
Why?
|
| Fresh Water | 4 | 2009 | 48 | 0.430 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 239 | 0.430 |
Why?
|
| DDT | 3 | 2010 | 15 | 0.430 |
Why?
|
| Research Design | 3 | 2021 | 385 | 0.420 |
Why?
|
| Alkaline Phosphatase | 4 | 2019 | 54 | 0.420 |
Why?
|
| Arsenic Poisoning | 2 | 2004 | 6 | 0.420 |
Why?
|
| Soil Pollutants | 1 | 2015 | 105 | 0.420 |
Why?
|
| Quality of Life | 2 | 2017 | 616 | 0.420 |
Why?
|
| Magnesium | 1 | 2014 | 94 | 0.410 |
Why?
|
| Internationality | 2 | 2011 | 37 | 0.410 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 47 | 0.410 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2022 | 465 | 0.410 |
Why?
|
| Transcriptional Activation | 3 | 2004 | 173 | 0.410 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2025 | 120 | 0.410 |
Why?
|
| Biocompatible Materials | 2 | 2015 | 108 | 0.410 |
Why?
|
| Flow Cytometry | 5 | 2015 | 411 | 0.400 |
Why?
|
| Asthma | 2 | 2016 | 416 | 0.400 |
Why?
|
| Fishes | 2 | 2009 | 73 | 0.400 |
Why?
|
| Cell Death | 4 | 2009 | 278 | 0.400 |
Why?
|
| Gene Expression Regulation | 5 | 2011 | 1070 | 0.390 |
Why?
|
| Malondialdehyde | 5 | 2011 | 42 | 0.390 |
Why?
|
| United States | 8 | 2025 | 5205 | 0.380 |
Why?
|
| Coumestrol | 2 | 2010 | 5 | 0.380 |
Why?
|
| Water Pollutants | 2 | 2005 | 17 | 0.380 |
Why?
|
| Air Pollutants, Occupational | 2 | 2003 | 10 | 0.380 |
Why?
|
| DNA Replication | 2 | 2010 | 148 | 0.380 |
Why?
|
| Vicia faba | 1 | 2012 | 2 | 0.370 |
Why?
|
| Macrocyclic Compounds | 1 | 2012 | 12 | 0.370 |
Why?
|
| Glutathione Peroxidase | 4 | 2019 | 112 | 0.370 |
Why?
|
| Flounder | 1 | 2012 | 1 | 0.370 |
Why?
|
| Otolithic Membrane | 1 | 2012 | 1 | 0.370 |
Why?
|
| Lead Poisoning | 2 | 2010 | 25 | 0.370 |
Why?
|
| Paclitaxel | 1 | 2012 | 64 | 0.370 |
Why?
|
| Iron | 1 | 2014 | 251 | 0.370 |
Why?
|
| Necrosis | 1 | 2012 | 54 | 0.370 |
Why?
|
| Health Facilities | 1 | 2012 | 32 | 0.370 |
Why?
|
| Mice | 10 | 2022 | 6644 | 0.370 |
Why?
|
| Perciformes | 1 | 2012 | 15 | 0.360 |
Why?
|
| Cold Temperature | 1 | 2012 | 40 | 0.360 |
Why?
|
| Rivers | 4 | 2008 | 51 | 0.360 |
Why?
|
| Catfishes | 1 | 2011 | 10 | 0.350 |
Why?
|
| Metallothionein | 4 | 2010 | 20 | 0.350 |
Why?
|
| Response Elements | 2 | 2009 | 55 | 0.350 |
Why?
|
| Parathion | 1 | 2011 | 3 | 0.350 |
Why?
|
| Aspartate Aminotransferases | 3 | 2019 | 16 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 432 | 0.350 |
Why?
|
| Mitotic Index | 4 | 2015 | 10 | 0.350 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 118 | 0.350 |
Why?
|
| Tetrazolium Salts | 2 | 2011 | 36 | 0.350 |
Why?
|
| Alanine Transaminase | 3 | 2019 | 27 | 0.350 |
Why?
|
| Disaster Planning | 1 | 2012 | 62 | 0.340 |
Why?
|
| Rats | 9 | 2019 | 3735 | 0.340 |
Why?
|
| Nickel | 1 | 2011 | 23 | 0.340 |
Why?
|
| Disasters | 1 | 2012 | 79 | 0.340 |
Why?
|
| Thiazoles | 2 | 2011 | 76 | 0.330 |
Why?
|
| Minority Health | 2 | 2022 | 95 | 0.320 |
Why?
|
| Leukocytes | 1 | 2010 | 80 | 0.320 |
Why?
|
| Tropical Climate | 1 | 2010 | 23 | 0.320 |
Why?
|
| Mitochondria | 1 | 2014 | 523 | 0.320 |
Why?
|
| Particulate Matter | 3 | 2023 | 83 | 0.320 |
Why?
|
| Milk, Human | 1 | 2010 | 51 | 0.320 |
Why?
|
| Cyclin D1 | 2 | 2009 | 44 | 0.310 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 307 | 0.310 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 64 | 0.310 |
Why?
|
| Cyclin A1 | 1 | 2009 | 1 | 0.310 |
Why?
|
| Estrogens | 2 | 2010 | 203 | 0.300 |
Why?
|
| Potassium Dichromate | 1 | 2009 | 3 | 0.300 |
Why?
|
| Lead Poisoning, Nervous System | 1 | 2009 | 5 | 0.300 |
Why?
|
| Escherichia coli O157 | 2 | 2006 | 17 | 0.300 |
Why?
|
| Micronucleus Tests | 4 | 2012 | 16 | 0.300 |
Why?
|
| Cyclonic Storms | 1 | 2010 | 80 | 0.290 |
Why?
|
| Breast Feeding | 1 | 2010 | 126 | 0.290 |
Why?
|
| Skin | 1 | 2010 | 187 | 0.290 |
Why?
|
| Feces | 2 | 2006 | 132 | 0.280 |
Why?
|
| Communication | 1 | 2010 | 210 | 0.280 |
Why?
|
| Mutagenicity Tests | 3 | 2015 | 24 | 0.280 |
Why?
|
| Mitogens | 2 | 2004 | 10 | 0.280 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 74 | 0.270 |
Why?
|
| Metals | 2 | 2022 | 114 | 0.270 |
Why?
|
| Snails | 4 | 2008 | 32 | 0.270 |
Why?
|
| Healthcare Disparities | 2 | 2011 | 590 | 0.270 |
Why?
|
| Hexachlorobenzene | 1 | 2007 | 3 | 0.270 |
Why?
|
| Particle Size | 3 | 2019 | 272 | 0.270 |
Why?
|
| Mercury Poisoning, Nervous System | 1 | 2007 | 1 | 0.270 |
Why?
|
| Mercury Compounds | 1 | 2007 | 3 | 0.270 |
Why?
|
| Risk Assessment | 6 | 2010 | 863 | 0.270 |
Why?
|
| Louisiana | 5 | 2006 | 50 | 0.260 |
Why?
|
| Ecology | 1 | 2007 | 33 | 0.260 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2007 | 34 | 0.260 |
Why?
|
| Research Personnel | 3 | 2025 | 206 | 0.260 |
Why?
|
| Phosphorylation | 2 | 2021 | 986 | 0.250 |
Why?
|
| Cell Line | 5 | 2016 | 1410 | 0.250 |
Why?
|
| Shellfish | 2 | 2008 | 14 | 0.250 |
Why?
|
| Rain | 1 | 2006 | 10 | 0.240 |
Why?
|
| Tetrachloroethylene | 1 | 2006 | 1 | 0.240 |
Why?
|
| Growth Inhibitors | 1 | 2005 | 29 | 0.230 |
Why?
|
| Body Size | 1 | 2006 | 49 | 0.230 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2005 | 44 | 0.230 |
Why?
|
| Water Pollution | 1 | 2005 | 13 | 0.230 |
Why?
|
| Ethyl Chloride | 1 | 2005 | 3 | 0.230 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2005 | 7 | 0.230 |
Why?
|
| Campylobacter Infections | 1 | 2005 | 8 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 734 | 0.230 |
Why?
|
| Atrazine | 2 | 2004 | 8 | 0.230 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 3156 | 0.230 |
Why?
|
| Dysentery, Bacillary | 1 | 2005 | 14 | 0.230 |
Why?
|
| Adult | 11 | 2022 | 13872 | 0.230 |
Why?
|
| Signal Transduction | 5 | 2018 | 2157 | 0.230 |
Why?
|
| Salmonella Infections | 1 | 2005 | 16 | 0.230 |
Why?
|
| Cytochromes c | 2 | 2015 | 48 | 0.230 |
Why?
|
| Acetylcholinesterase | 1 | 2005 | 56 | 0.220 |
Why?
|
| Melanocytes | 1 | 2004 | 7 | 0.220 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2015 | 90 | 0.220 |
Why?
|
| Ictaluridae | 1 | 2004 | 8 | 0.220 |
Why?
|
| Toxicity Tests | 3 | 2018 | 44 | 0.220 |
Why?
|
| Drug Synergism | 2 | 2022 | 195 | 0.210 |
Why?
|
| Prevalence | 4 | 2018 | 1612 | 0.210 |
Why?
|
| Hydantoins | 1 | 2004 | 5 | 0.210 |
Why?
|
| Fungicides, Industrial | 1 | 2004 | 6 | 0.210 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2004 | 4 | 0.210 |
Why?
|
| Keratinocytes | 1 | 2004 | 67 | 0.210 |
Why?
|
| Cell Fusion | 1 | 2024 | 19 | 0.210 |
Why?
|
| Molluscacides | 3 | 1996 | 4 | 0.210 |
Why?
|
| Food Contamination | 3 | 2014 | 57 | 0.210 |
Why?
|
| Mutagenesis | 1 | 2004 | 91 | 0.200 |
Why?
|
| Cell Culture Techniques | 3 | 2019 | 152 | 0.200 |
Why?
|
| Dendritic Cells | 1 | 2004 | 132 | 0.200 |
Why?
|
| Mercury Poisoning | 1 | 2003 | 5 | 0.200 |
Why?
|
| Vitamin K | 1 | 2023 | 9 | 0.200 |
Why?
|
| Nitrogen Dioxide | 1 | 2023 | 17 | 0.200 |
Why?
|
| Gene Regulatory Networks | 2 | 2022 | 149 | 0.200 |
Why?
|
| Muscular Diseases | 1 | 2003 | 22 | 0.200 |
Why?
|
| Inhalation Exposure | 1 | 2003 | 44 | 0.200 |
Why?
|
| Injections, Intraperitoneal | 2 | 2015 | 60 | 0.200 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 38 | 0.200 |
Why?
|
| MicroRNAs | 2 | 2019 | 518 | 0.200 |
Why?
|
| 5-Methylcytosine | 1 | 2022 | 7 | 0.190 |
Why?
|
| Vitamin A | 1 | 2023 | 86 | 0.190 |
Why?
|
| Vitamins | 1 | 2023 | 81 | 0.190 |
Why?
|
| Cattle | 4 | 2019 | 498 | 0.190 |
Why?
|
| DNA, Single-Stranded | 2 | 2019 | 40 | 0.190 |
Why?
|
| Occupational Exposure | 1 | 2003 | 91 | 0.190 |
Why?
|
| Rabbits | 1 | 2023 | 278 | 0.190 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 704 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2015 | 160 | 0.190 |
Why?
|
| China | 2 | 2020 | 229 | 0.190 |
Why?
|
| Embryo, Nonmammalian | 2 | 2018 | 59 | 0.190 |
Why?
|
| Niclosamide | 3 | 1996 | 9 | 0.180 |
Why?
|
| Blotting, Western | 3 | 2015 | 883 | 0.180 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2022 | 33 | 0.180 |
Why?
|
| Thyroid Gland | 1 | 2021 | 23 | 0.180 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2014 | 157 | 0.170 |
Why?
|
| Cyclin E | 1 | 2021 | 14 | 0.170 |
Why?
|
| Cooperative Behavior | 2 | 2025 | 269 | 0.170 |
Why?
|
| Trinitrotoluene | 1 | 2001 | 15 | 0.170 |
Why?
|
| E2F1 Transcription Factor | 1 | 2021 | 22 | 0.170 |
Why?
|
| Solid Phase Extraction | 2 | 2014 | 13 | 0.170 |
Why?
|
| Drug Compounding | 1 | 2022 | 93 | 0.170 |
Why?
|
| Epithelium | 1 | 2021 | 78 | 0.170 |
Why?
|
| Lipid Peroxides | 2 | 2011 | 19 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 184 | 0.170 |
Why?
|
| Transcription Factor CHOP | 4 | 2006 | 11 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2023 | 389 | 0.170 |
Why?
|
| Seasons | 2 | 2015 | 139 | 0.170 |
Why?
|
| Gonads | 1 | 2020 | 21 | 0.160 |
Why?
|
| Goldfish | 2 | 2010 | 18 | 0.160 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 7 | 0.160 |
Why?
|
| Fertility | 1 | 2020 | 62 | 0.160 |
Why?
|
| Incidence | 2 | 2018 | 1078 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 167 | 0.160 |
Why?
|
| Vaccination | 1 | 2022 | 355 | 0.160 |
Why?
|
| Nitric Oxide | 1 | 2023 | 386 | 0.160 |
Why?
|
| Geology | 2 | 2010 | 6 | 0.160 |
Why?
|
| Ovary | 1 | 2020 | 113 | 0.150 |
Why?
|
| PC12 Cells | 3 | 2014 | 93 | 0.150 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2019 | 1 | 0.150 |
Why?
|
| Infant | 3 | 2010 | 1175 | 0.150 |
Why?
|
| Lythraceae | 1 | 2019 | 3 | 0.150 |
Why?
|
| Alleles | 1 | 2020 | 352 | 0.150 |
Why?
|
| NF-kappa B | 3 | 2016 | 358 | 0.150 |
Why?
|
| India | 2 | 2019 | 108 | 0.150 |
Why?
|
| Commerce | 1 | 2020 | 95 | 0.150 |
Why?
|
| Vibrio | 1 | 1999 | 19 | 0.150 |
Why?
|
| Lethal Dose 50 | 3 | 2011 | 32 | 0.150 |
Why?
|
| Enzyme Activation | 3 | 2010 | 462 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2022 | 403 | 0.150 |
Why?
|
| Testis | 1 | 2020 | 207 | 0.150 |
Why?
|
| Child | 6 | 2016 | 3443 | 0.150 |
Why?
|
| Garlic | 1 | 2019 | 31 | 0.150 |
Why?
|
| Biostatistics | 1 | 2018 | 10 | 0.150 |
Why?
|
| Risk Factors | 4 | 2018 | 3994 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2014 | 241 | 0.150 |
Why?
|
| Biotransformation | 1 | 2018 | 69 | 0.150 |
Why?
|
| Behavioral Research | 1 | 2019 | 41 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1621 | 0.140 |
Why?
|
| Limit of Detection | 4 | 2022 | 94 | 0.140 |
Why?
|
| Microfluidics | 1 | 2018 | 45 | 0.140 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 64 | 0.140 |
Why?
|
| Health Policy | 1 | 2020 | 184 | 0.140 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 592 | 0.140 |
Why?
|
| Life Cycle Stages | 1 | 2018 | 29 | 0.140 |
Why?
|
| Gene Expression | 1 | 2001 | 701 | 0.140 |
Why?
|
| Nanotechnology | 2 | 2010 | 176 | 0.130 |
Why?
|
| Ecotoxicology | 2 | 2009 | 14 | 0.130 |
Why?
|
| Temperature | 3 | 2009 | 313 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 166 | 0.130 |
Why?
|
| Curcumin | 1 | 2019 | 118 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2018 | 735 | 0.130 |
Why?
|
| Hazardous Waste | 1 | 1996 | 4 | 0.130 |
Why?
|
| Nanostructures | 1 | 2019 | 161 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 749 | 0.120 |
Why?
|
| Collagen Type III | 1 | 2016 | 9 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 1081 | 0.120 |
Why?
|
| Respiratory System | 1 | 2016 | 31 | 0.120 |
Why?
|
| Aged | 4 | 2019 | 8214 | 0.120 |
Why?
|
| Nanofibers | 1 | 2016 | 17 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 300 | 0.120 |
Why?
|
| Matrix Metalloproteinases | 1 | 2016 | 49 | 0.120 |
Why?
|
| Glutathione Transferase | 1 | 2016 | 90 | 0.120 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 57 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 114 | 0.120 |
Why?
|
| Middle Aged | 6 | 2019 | 12222 | 0.120 |
Why?
|
| Escherichia coli | 3 | 2022 | 460 | 0.120 |
Why?
|
| Coal | 1 | 2015 | 10 | 0.120 |
Why?
|
| Wetlands | 1 | 2015 | 15 | 0.120 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 18 | 0.110 |
Why?
|
| Poultry | 2 | 2005 | 13 | 0.110 |
Why?
|
| Adolescent | 6 | 2016 | 6081 | 0.110 |
Why?
|
| Wound Healing | 1 | 2016 | 88 | 0.110 |
Why?
|
| Femur | 1 | 2015 | 47 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 25 | 0.110 |
Why?
|
| Random Allocation | 1 | 2015 | 147 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2018 | 1271 | 0.110 |
Why?
|
| Phosphorus | 1 | 2015 | 65 | 0.110 |
Why?
|
| Texas | 3 | 2016 | 457 | 0.110 |
Why?
|
| Cell Movement | 2 | 2016 | 655 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 159 | 0.110 |
Why?
|
| Quantum Dots | 1 | 2015 | 38 | 0.110 |
Why?
|
| Pheochromocytoma | 1 | 2014 | 12 | 0.110 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2014 | 4 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2015 | 260 | 0.110 |
Why?
|
| Wine | 1 | 2014 | 9 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 216 | 0.110 |
Why?
|
| Cytokines | 1 | 2018 | 678 | 0.110 |
Why?
|
| Sulfur Dioxide | 1 | 2014 | 9 | 0.110 |
Why?
|
| Aflatoxins | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cell Division | 3 | 2004 | 311 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2014 | 20 | 0.110 |
Why?
|
| HIV Infections | 1 | 2008 | 2586 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2016 | 1546 | 0.110 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 76 | 0.110 |
Why?
|
| New York | 1 | 2014 | 93 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 234 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 81 | 0.100 |
Why?
|
| Disease Progression | 1 | 2016 | 667 | 0.100 |
Why?
|
| Soil | 1 | 2015 | 171 | 0.100 |
Why?
|
| Thymidine | 2 | 2010 | 15 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 611 | 0.100 |
Why?
|
| Electrophoresis, Microchip | 1 | 2013 | 21 | 0.100 |
Why?
|
| Oxygen | 3 | 2006 | 218 | 0.100 |
Why?
|
| Glutathione | 1 | 2014 | 171 | 0.100 |
Why?
|
| Protein Transport | 1 | 2014 | 296 | 0.100 |
Why?
|
| Cameroon | 3 | 2008 | 35 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2014 | 74 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 161 | 0.100 |
Why?
|
| Amino Acids | 1 | 2013 | 148 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2012 | 92 | 0.090 |
Why?
|
| Heat-Shock Proteins | 2 | 2004 | 57 | 0.090 |
Why?
|
| Serbia | 1 | 2012 | 1 | 0.090 |
Why?
|
| Croatia | 1 | 2012 | 4 | 0.090 |
Why?
|
| Meristem | 1 | 2012 | 6 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2005 | 241 | 0.090 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 333 | 0.090 |
Why?
|
| State Medicine | 1 | 2012 | 8 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2006 | 972 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 140 | 0.090 |
Why?
|
| Borohydrides | 1 | 2012 | 5 | 0.090 |
Why?
|
| Calcium Carbonate | 1 | 2012 | 11 | 0.090 |
Why?
|
| Volatilization | 1 | 2012 | 23 | 0.090 |
Why?
|
| Methylmercury Compounds | 1 | 2012 | 4 | 0.090 |
Why?
|
| Reducing Agents | 1 | 2012 | 13 | 0.090 |
Why?
|
| Poisoning | 1 | 2012 | 13 | 0.090 |
Why?
|
| Petroleum | 1 | 2012 | 20 | 0.090 |
Why?
|
| Safety | 1 | 2012 | 54 | 0.090 |
Why?
|
| Ammonium Sulfate | 1 | 1991 | 4 | 0.090 |
Why?
|
| Health | 1 | 2012 | 30 | 0.090 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2011 | 7 | 0.090 |
Why?
|
| Electrophoresis, Capillary | 1 | 2011 | 20 | 0.090 |
Why?
|
| Urea | 1 | 1991 | 46 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 526 | 0.090 |
Why?
|
| Schistosoma mansoni | 1 | 1991 | 21 | 0.080 |
Why?
|
| Transaminases | 1 | 2010 | 8 | 0.080 |
Why?
|
| Phenols | 2 | 2019 | 107 | 0.080 |
Why?
|
| Colostrum | 1 | 2010 | 1 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2009 | 388 | 0.080 |
Why?
|
| Hospitalization | 1 | 2014 | 485 | 0.080 |
Why?
|
| Obesity | 1 | 2018 | 1151 | 0.080 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2010 | 29 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2010 | 27 | 0.080 |
Why?
|
| Nanomedicine | 1 | 2010 | 52 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 141 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 105 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2010 | 79 | 0.080 |
Why?
|
| Young Adult | 4 | 2021 | 5080 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 152 | 0.080 |
Why?
|
| Calibration | 2 | 2019 | 63 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2012 | 760 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 310 | 0.070 |
Why?
|
| Sister Chromatid Exchange | 1 | 2009 | 6 | 0.070 |
Why?
|
| Phenylethyl Alcohol | 1 | 2008 | 3 | 0.070 |
Why?
|
| Air Movements | 1 | 2008 | 3 | 0.070 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2010 | 95 | 0.070 |
Why?
|
| Chlorpromazine | 1 | 2008 | 6 | 0.070 |
Why?
|
| Computer Literacy | 1 | 2008 | 5 | 0.070 |
Why?
|
| Time | 1 | 2008 | 15 | 0.070 |
Why?
|
| Hela Cells | 1 | 2010 | 376 | 0.070 |
Why?
|
| Tubulin | 1 | 2009 | 96 | 0.070 |
Why?
|
| Conservation of Natural Resources | 1 | 2008 | 48 | 0.070 |
Why?
|
| Tylenchoidea | 1 | 2008 | 4 | 0.070 |
Why?
|
| Antinematodal Agents | 1 | 2008 | 5 | 0.070 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2009 | 38 | 0.070 |
Why?
|
| Models, Animal | 1 | 2009 | 151 | 0.070 |
Why?
|
| Chitin | 1 | 2008 | 20 | 0.070 |
Why?
|
| Industrial Waste | 1 | 2008 | 16 | 0.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2008 | 74 | 0.070 |
Why?
|
| Food Industry | 1 | 2008 | 12 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 291 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 223 | 0.070 |
Why?
|
| Computational Biology | 1 | 2010 | 327 | 0.070 |
Why?
|
| Phenylalanine | 2 | 2022 | 25 | 0.070 |
Why?
|
| Thiobarbiturates | 1 | 2007 | 4 | 0.070 |
Why?
|
| Mexico | 1 | 2008 | 298 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 226 | 0.070 |
Why?
|
| Free Radicals | 1 | 2007 | 70 | 0.070 |
Why?
|
| Silver Staining | 1 | 2007 | 7 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2007 | 52 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2007 | 55 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2007 | 240 | 0.060 |
Why?
|
| Water Supply | 1 | 2006 | 60 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1063 | 0.060 |
Why?
|
| Luminescence | 1 | 2006 | 31 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2006 | 26 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2005 | 67 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2005 | 54 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 706 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 26 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 310 | 0.060 |
Why?
|
| Phosphates | 1 | 2005 | 54 | 0.060 |
Why?
|
| Vitellogenins | 1 | 2004 | 4 | 0.060 |
Why?
|
| Potassium | 1 | 2005 | 109 | 0.050 |
Why?
|
| Mitosis | 1 | 2005 | 114 | 0.050 |
Why?
|
| Time Factors | 3 | 2013 | 1857 | 0.050 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2004 | 3 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 153 | 0.050 |
Why?
|
| Breast | 1 | 2005 | 139 | 0.050 |
Why?
|
| Artificial Gene Fusion | 1 | 2004 | 5 | 0.050 |
Why?
|
| Nitrogen | 1 | 2005 | 84 | 0.050 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2004 | 22 | 0.050 |
Why?
|
| Schistosomiasis | 2 | 1996 | 19 | 0.050 |
Why?
|
| Body Weight | 1 | 2006 | 429 | 0.050 |
Why?
|
| Copper | 1 | 2005 | 134 | 0.050 |
Why?
|
| Immune System | 1 | 2004 | 41 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 65 | 0.050 |
Why?
|
| Pharmacokinetics | 1 | 2003 | 4 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 70 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2004 | 91 | 0.050 |
Why?
|
| Nausea | 1 | 2003 | 12 | 0.050 |
Why?
|
| Vomiting | 1 | 2003 | 14 | 0.050 |
Why?
|
| Risk Management | 1 | 2003 | 8 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2004 | 63 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 33 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2003 | 148 | 0.050 |
Why?
|
| Bacteria | 1 | 2006 | 293 | 0.050 |
Why?
|
| Carcinogenicity Tests | 1 | 2003 | 5 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 314 | 0.050 |
Why?
|
| Acetaldehyde | 1 | 2022 | 11 | 0.050 |
Why?
|
| Proteins | 1 | 2006 | 382 | 0.050 |
Why?
|
| Cytosine | 1 | 2022 | 33 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2003 | 52 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 211 | 0.050 |
Why?
|
| Age Factors | 1 | 2006 | 1154 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 518 | 0.050 |
Why?
|
| Lung | 1 | 2005 | 492 | 0.050 |
Why?
|
| Mutation | 1 | 2007 | 1177 | 0.050 |
Why?
|
| Faculty | 1 | 2022 | 105 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 279 | 0.050 |
Why?
|
| Adenine | 1 | 2022 | 46 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2001 | 26 | 0.040 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2022 | 110 | 0.040 |
Why?
|
| Biomphalaria | 2 | 1991 | 18 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2001 | 95 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2001 | 52 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 99 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2001 | 127 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2020 | 126 | 0.040 |
Why?
|
| Pain | 1 | 2003 | 290 | 0.040 |
Why?
|
| Biological Assay | 1 | 2019 | 63 | 0.040 |
Why?
|
| DNA | 1 | 2022 | 592 | 0.040 |
Why?
|
| Carbon Tetrachloride | 1 | 2019 | 3 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2019 | 40 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 1999 | 26 | 0.040 |
Why?
|
| DNA Probes | 1 | 2018 | 32 | 0.040 |
Why?
|
| Macrophages, Peritoneal | 1 | 2018 | 23 | 0.040 |
Why?
|
| Georgia | 1 | 2019 | 192 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 89 | 0.040 |
Why?
|
| Species Specificity | 1 | 1999 | 286 | 0.040 |
Why?
|
| Flavonoids | 1 | 2019 | 100 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 408 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 107 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 128 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2017 | 23 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 283 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2019 | 193 | 0.030 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 1996 | 4 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 437 | 0.030 |
Why?
|
| Brain | 1 | 2005 | 1472 | 0.030 |
Why?
|
| Disease Vectors | 1 | 1996 | 11 | 0.030 |
Why?
|
| Meat | 1 | 1996 | 46 | 0.030 |
Why?
|
| National Health Programs | 1 | 1996 | 20 | 0.030 |
Why?
|
| Rural Health | 1 | 1996 | 55 | 0.030 |
Why?
|
| Overweight | 1 | 2018 | 249 | 0.030 |
Why?
|
| Population Groups | 1 | 2016 | 59 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2015 | 17 | 0.030 |
Why?
|
| Water | 2 | 2008 | 316 | 0.030 |
Why?
|
| Materials Testing | 1 | 2015 | 101 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1600 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 24 | 0.030 |
Why?
|
| Adsorption | 1 | 2014 | 74 | 0.030 |
Why?
|
| Depression | 1 | 2021 | 863 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 189 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2014 | 154 | 0.030 |
Why?
|
| Equipment Design | 1 | 2013 | 145 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 758 | 0.020 |
Why?
|
| Polymers | 1 | 2014 | 155 | 0.020 |
Why?
|
| Indoles | 1 | 2014 | 187 | 0.020 |
Why?
|
| Reference Standards | 1 | 2012 | 55 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2011 | 35 | 0.020 |
Why?
|
| Tropical Medicine | 1 | 1991 | 10 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 120 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2011 | 169 | 0.020 |
Why?
|
| Social Justice | 1 | 2011 | 65 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2010 | 60 | 0.020 |
Why?
|
| Public Policy | 1 | 2009 | 36 | 0.020 |
Why?
|
| Health Services | 1 | 2009 | 61 | 0.020 |
Why?
|
| Attitude | 1 | 2009 | 108 | 0.020 |
Why?
|
| Workplace | 1 | 2009 | 92 | 0.020 |
Why?
|
| Crops, Agricultural | 1 | 2008 | 36 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 638 | 0.020 |
Why?
|
| Triazines | 1 | 2007 | 25 | 0.020 |
Why?
|
| Schools | 1 | 2009 | 283 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2007 | 62 | 0.020 |
Why?
|
| Plants | 1 | 2008 | 113 | 0.020 |
Why?
|
| Filtration | 1 | 2006 | 17 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2006 | 55 | 0.020 |
Why?
|
| Quality Control | 1 | 2006 | 42 | 0.020 |
Why?
|
| Recreation | 1 | 2006 | 43 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 1234 | 0.020 |
Why?
|
| Plant Roots | 1 | 2008 | 180 | 0.010 |
Why?
|
| Play and Playthings | 1 | 1994 | 13 | 0.010 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2004 | 20 | 0.010 |
Why?
|
| Endocrine System | 1 | 2004 | 12 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 87 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2004 | 6 | 0.010 |
Why?
|
| Xenobiotics | 1 | 2004 | 16 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 665 | 0.010 |
Why?
|
| Benzhydryl Compounds | 1 | 2004 | 50 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 249 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2004 | 117 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 1082 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1996 | 259 | 0.010 |
Why?
|